PD-1 Checkpoint Blockade in Patients for Acute Myeloid Leukemia after HSCT Relapse Resulted in Severe GVHD and sHLH

Treatment with immune checkpoint inhibitors (ICI) such as carrizumab leads to immune-mediated adverse effects including severe acute graft versus host disease (aGVHD) and secondary hemophagocytic syndrome (sHLH). Herein, we present two cases where aGVHD and sHLH developed after ICI administration, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Zhi zhuo, Zhou, Mi, Ling, Jing, Cao, Lan, Kong, Lingjun, Cheng, Shengqin, Xiao, Peifang, Hu, Shaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800091/
https://www.ncbi.nlm.nih.gov/pubmed/36590870
http://dx.doi.org/10.1155/2022/1705905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800091/
https://www.ncbi.nlm.nih.gov/pubmed/36590870
http://dx.doi.org/10.1155/2022/1705905

Ejemplares similares